Spiro-benzodioxoles and their use as CB1 antagonists

Details for Australian Patent Application No. 2005211451 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Plancher, Jean-Marc; Taylor, Sven

Agent Spruson & Ferguson

Pub. Number AU-B-2005211451

PCT Pub. Number WO2005/075450

Priority 04100304.7 28.01.04 EP

Filing date 18 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 29 April 2010

International Classifications

C07D 317/72 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/075450 Priority application(s): WO2005/075450

29 April 2010 Application Accepted

  Published as AU-B-2005211451

26 August 2010 Standard Patent Sealed

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211453-Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it

2005211448-Bisarylurea derivatives